Social Management in Pharmaceutical Healthcare Sector

Aims: There is an increase in demand for the social environment regulations in the pharmaceutical companies, which is a crucial strategy issue in long-term planning due to the incidence of social influence. The influence of society over resource allocation and its control over innovation is all the perceptions of today's needs. This research aims to highlight the managerial issues faced by the pharmaceutical healthcare sector of Ukraine. Our study is unique as we have analyzed the whole pharmaceutical sector of Ukraine in terms of management issues. There is no such research done yet. In addition, we have also researched the official databases and laid down the models for management practices.

Methodology: The research was done to analyze the major issues in the social management of the pharmaceutical healthcare system. In addition, the related studies based on managerial issues were studied. The following databases were used to study the guidelines: World Health Organisation, Food and Drug Administration, Internationational Council for Harmonization, and European Union.

Results: The results were found to be when comparing behavioural studies with non-behavioural; non-behavioural was found to be 64%, whereas behavioural was 34%. To have an in-depth knowledge of the managerial issues, we have provided an inverted tree diagram representing the significant issues in pricing and medical expenditures. These contributed 21.7% of non-behavioural studies, and in behavioural studies, it was found to be consumer or physician-level behaviour 23.4% contributing the central part of the issue.

Conclusion: Here we conclude that the pharmaceutical healthcare sector plays a crucial role in the global healthcare of the general public-facing management issues; hence should be analyzed and follow the guidelines to analyze the issues within the company and set goals.

Therefore, improving the management of the pharma sector will, in turn, improve public health in Ukraine.